التفاصيل البيبلوغرافية
| العنوان: |
Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study. |
| المؤلفون: |
Doo Sun Sim, Dae Young Hyun, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Myung Ho Jeong, Sang Rok Lee, Jei Keon Chae, Keun Ho Park, Young Youp Koh, Kyeong Ho Yun, Seok Kyu Oh, Seung Jae Joo, Sun Ho Hwang, Jong Pil Park, Jay Young Rhew, Su Hyun Kim, Jang Hyun Cho, Seung Uk Lee, Dong Goo Kang |
| المصدر: |
Chonnam Medical Journal; Jan2024, Vol. 60 Issue 1, p78-86, 9p |
| مصطلحات موضوعية: |
MYOCARDIAL infarction, CORONARY artery disease, CORONARY arteries, EAST Asians, INTRAVASCULAR ultrasonography, KOREANS |
| مستخلص: |
There are limited data on outcomes after implantation of everolimus-eluting stents (EES) in East Asian patients with small vessel coronary lesions. A total of 1,600 patients treated with XIENCE EES (Abbott Vascular, CA, USA) were divided into the small vessel group treated with one =2.5 mm stent (n=119) and the non-small vessel group treated with one =2.75 mm stent (n=933). The primary end point was a patient-oriented composite outcome (POCO), a composite of all-cause death, myocardial infarction (MI), and any repeat revascularization at 12 months. The key secondary end point was a device-oriented composite outcome (DOCO), a composite of cardiovascular death, target-vessel MI, and target lesion revascularization at 12 months. The small vessel group was more often female, hypertensive, less likely to present with ST-elevation MI, and more often treated for the left circumflex artery, whereas the non-small vessel group more often had type B2/C lesions, underwent intravascular ultrasound, and received unfractionated heparin. In the propensity matched cohort, the mean stent diameter was 2.5±0.0 mm and 3.1±0.4 mm in the small and non-small vessel groups, respectively. Propensity-adjusted POCO at 12 months was 6.0% in the small vessel group and 4.3% in the non-small vessel group (p=0.558). There was no significant difference in DOCO at 12 months (small vessel group: 4.3% and non-small vessel group: 1.7%, p=0.270). Outcomes of XIENCE EES for small vessel disease were comparable to those for non-small vessel disease at 12-month clinical follow-up in real-world Korean patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Chonnam Medical Journal is the property of Chonnam Medical Journal and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder